Clinical Trials Browser

Interventional × Mesothelioma, Malignant × fresolimumab × Clear all

NCT01112293 2020-04-10

Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

Phase 2 Completed

14 enrolled 10 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant